Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | CFTR | P13569 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 1/20 | 0.51 |
| ▸ | CA5A | P35218 | 1/20 | 0.51 |
| ▸ | CA9 | Q16790 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL25289042 | 0.98 | ALDH1A1 (0.60) | ALDH1A1LMNAHSD17B10CFTRTSHR | |
| Hydrochloric Acid SCHEMBL2159177 | 0.98 | ALDH1A1 (0.60) | ALDH1A1LMNAHSD17B10CFTRTSHR | |
| SCHEMBL3959092 | 0.86 | ALDH1A1 (0.51) | ALDH1A1LMNAHSD17B10CFTRTSHR | |
| SCHEMBL4739142 | 0.85 | ALDH1A1 (0.68) | ALDH1A1LMNAHSD17B10CFTRTSHR | |
| SCHEMBL70322 | 0.84 | ALDH1A1 (0.66) | ALDH1A1LMNAHSD17B10CFTRTSHR | |
| SCHEMBL10360804 | 0.84 | ALDH1A1 (0.77) | ALDH1A1LMNAHSD17B10CFTRTSHR | |
| SCHEMBL156281 | 0.84 | ALDH1A1 (0.66) | ALDH1A1LMNAHSD17B10CFTRTSHR | |
| Hydrochloric Acid SCHEMBL4443950 | 0.84 | ALDH1A1 (0.66) | ALDH1A1LMNAHSD17B10CFTRTSHR | |
| SCHEMBL1035344 | 0.84 | ALDH1A1 (0.53) | ALDH1A1LMNAHSD17B10CFTRTSHR | |
| SCHEMBL4443811 | 0.84 | MRGPRX4 (0.50) | ALDH1A1LMNAHSD17B10CFTRTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109293584-A | Target the other structure modulating compound SPAM of small molecule and its preparation method and application of neuropeptide receptor PAC1-R | 暨南大学 | 2019-02-01 | — | — | CN | claimed |
| CN-107096036-A | A kind of preparation method and applications of pH responsive types hyaluronic acid Doxorubicin nano-prodrug | 武汉理工大学 | 2017-08-29 | — | — | CN | claimed |
| CN-104610166-B | Pyrimidine benzyl hydroxamic acid histone deacetylases inhibitor and preparation method and application | 山东大学 | 2017-06-13 | — | — | CN | claimed |
| CN-104610166-A | Pyrimidine benzyl hydroxamic acid histone deacetylase inhibitor, and preparation method and application thereof | UNIV SHANDONG | 2015-05-13 | — | — | CN | claimed |
| EP-4598923-A1 | SUPRAMOLECULAR POLYMER THERAPEUTICS AND DIAGNOSTICS | The Regents of the University of California (US) | 2025-08-13 | — | — | EP | disclosed |
| WO-2024201308-A1 | NOVEL BENZIMIDAZOLONE DERIVATIVE COMPOUND AS AUTOTAXIN INHIBITOR | 주식회사 엘지화학 | 2024-10-03 | — | — | WO | disclosed |
| US-20240199604-A1 | SUPRAMOLECULAR POLYMER THERAPEUTICS AND DIAGNOSTICS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-06-20 | — | — | US | disclosed |
| WO-2024059845-A1 | SUPRAMOLECULAR POLYMER THERAPEUTICS AND DIAGNOSTICS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-03-21 | — | — | WO | disclosed |
| WO-2024059845-A1 | SUPRAMOLECULAR POLYMER THERAPEUTICS AND DIAGNOSTICS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-03-21 | — | — | WO | disclosed |
| EP-3844143-B1 | TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES FOR PEPTIDE PURIFICATION | GYROS PROTEIN TECH AB (SE) | 2024-01-17 | — | — | EP | disclosed |
| US-11845752-B2 | Substituted imidazo[1,5-a]pyrazines for the treatment of hepatitis B | ALIGOS THERAPEUTICS, INC. (US) | 2023-12-19 | — | — | US | disclosed |
| EP-4010352-B1 | A METHOD FOR MODIFICATION OF PEPTIDES IMMOBILIZED ON A SOLID SUPPORT BY TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES | GYROS PROTEIN TECH AB (SE) | 2023-10-18 | — | — | EP | disclosed |
| US-6369270-B1 | CHEMICAL INTERMEDIATES | RHONE POULENC AGRICULTURE LIMITED (GB) | 2002-04-09 | — | — | US | disclosed |
| EP-1182199-A1 | PROCESS FOR PREPARING AMIC ACID ESTERS | IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) | 2002-02-27 | — | — | EP | disclosed |
| EP-0828721-B1 | 2-AMINO-BENZOXAZINONES FOR THE TREATMENT OF VIRAL INFECTIONS | SEARLE & CO (US) | 2001-11-14 | — | — | EP | disclosed |
| CN-1070480-C | 2-amino-benzoxanones for the treatment of viral infections | SEARLE & CO (US) | 2001-09-05 | — | — | CN | disclosed |
| EP-1122245-A2 | 2-Amino-benzoxazinones for the treatment of viral infections | G.D. Searle & Co. (US) | 2001-08-08 | — | — | EP | disclosed |
| US-5985872-A | THERAPEUTIC TREATMENT OF HERPES VIRAL INFECTION | G.D. SEARLE & CO. (US) | 1999-11-16 | — | — | US | disclosed |
| EP-0828721-A1 | 2-AMINO-BENZOXAZINONES FOR THE TREATMENT OF VIRAL INFECTIONS | G.D. SEARLE & CO. (US) | 1998-03-18 | — | — | EP | disclosed |
| WO-1996037485-A1 | 2-AMINO-BENZOXAZINONES FOR THE TREATMENT OF VIRAL INFECTIONS | G.D. SEARLE & CO. (US) | 1996-11-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240199604-A1 | SUPRAMOLECULAR POLYMER THERAPEUTICS AND DIAGNOSTICS | MAPT, HTT, PSEN1 | ALDH1A1 4342/4885LMNA 1102/4885HSD17B10 2517/4885 |
| US-11845752-B2 | Substituted imidazo[1,5-a]pyrazines for the treatment of hepatitis B | SLC10A1, HAVCR2, CYP3A5 | ALDH1A1 297/4885LMNA 2492/4885HSD17B10 360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.